XFLH signs letter of intent to acquire Renogen Biolab
XFLH Capital Corp and Renogen Biolab have signed a non-binding letter of intent for a business combination, seeking to finalize agreements by early 2027.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed